3D-QSAR and docking studies of benzoyl urea derivatives as tubulin-binding agents for antiproliferative activity (original) (raw)

Pharmacophore Modeling, Atom based 3D-QSAR and Docking Studies of Chalcone Derivatives as Tubulin Inhibitors

Naresh kandakatla, Geetha Chemistry

View PDFchevron_right

2-Oxoquinoline Arylaminothiazole Derivatives in Identifying Novel Potential Anticancer Agents by Applying 3D-QSAR, Docking, and Molecular Dynamics Simulation Studies

larbi elmchichi

Journal of the Mexican Chemical Society

View PDFchevron_right

Structural Investigation of Vinca domain tubulin binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations

Prakash Jha

Combinatorial chemistry & high throughput screening, 2017

View PDFchevron_right

Development of robust QSAR model using rapid overlay of crystal structures (ROCS) based alignment: a test case of Tubulin inhibitors

Reaz Uddin

Medicinal Chemistry Research, 2013

View PDFchevron_right

Pharmacophore modeling, 3D-QSAR, docking study and ADME prediction of acyl 1,3,4-thiadiazole amides and sulfonamides as antitubulin agents

Mohemmed Faraz Khan

Arabian Journal of Chemistry, 2016

View PDFchevron_right

Druglikeness Scoring and QSAR Modeling of 1,3,4-Thiadiazole Derivatives as Antitubulin Agents by Computational Calculations

Nabila Aoumeur

Journal of Bionanoscience, 2018

View PDFchevron_right

Molecular Modeling and Receptor-Dependent (RD) 3D-QSAR Approach to a Set of Antituberculosis Derivatives

Kerly Pasqualoto

QSAR & Combinatorial Science, 2009

View PDFchevron_right

Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin

Chetna Tyagi

BMC genomics, 2014

View PDFchevron_right

How to Deal with Low-Resolution Target Structures: Using SAR, Ensemble Docking, Hydropathic Analysis, and 3D-QSAR to Definitively Map the αβ-Tubulin Colchicine Site

John Gupton

Journal of Medicinal Chemistry, 2013

View PDFchevron_right

QSAR modeling, molecular docking studies and ADMET prediction on a series of phenylaminopyrimidine-(thio) urea derivatives as CK2 inhibitors

Hicham EL Hamdani

Materials Today: Proceedings, 2020

View PDFchevron_right

Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches

Kapil Kumar Goel

Molecules

View PDFchevron_right

Monte Carlo method based QSAR and docking studies of Pyrazoline and Benzoxazole derivatives as antitubercular agents

Monica Kachroo

Journal of Computational Methods in Molecular Design, 2016

View PDFchevron_right

Development of Structure Activity Correlation Model on Azetidin-2-ones as Tubulin Polymerization Inhibitors

Kavi Bhushan Singh Chouhan

View PDFchevron_right

Combined 3D-QSAR modeling and molecular docking study on multi-acting quinazoline derivatives as HER2 kinase inhibitors

Sako Mirzaie

View PDFchevron_right

Design and Biological Evaluation of Novel Tubulin Inhibitors as Antimitotic Agents Using a Pharmacophore Binding Model with Tubulin

Cheol Kyu Han

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models

g narahari sastry

Organic and Medicinal Chemistry Letters, 2011

View PDFchevron_right

QSAR, Pharmacophore Mapping and Molecular Docking of 2,4-Diaminoquinazoline as Antitubercular Scaffold: A Computational Hybrid Approach

mitali midya

2019

View PDFchevron_right

Insight into the structural requirement for Anticancer Activity: Pharmacophore Generation and 3D QSAR Analysis

Vivekanand Chatpalliwar

2015

View PDFchevron_right

Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking☆

Achaiah Garlapati

European Journal of Medicinal Chemistry, 2008

View PDFchevron_right

QSAR modeling of antitubercular activity of diverse organic compounds

Vasyl Kovalishyn, Filomena Martins

Chemometrics and Intelligent Laboratory Systems, 2011

View PDFchevron_right

A field based 3D QSAR model of novel anti-microtubule agent noscapine and its derivatives

Seneha Santoshi

International Journal of Fundamental and Applied Sciences (IJFAS)

View PDFchevron_right

An In silico Based Comparison of Drug Interactions in Wild and Mutant Human β-tubulin through Docking Studies

sudheer mohammed

Avicenna journal of medical biotechnology, 2014

View PDFchevron_right

Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors

Andrea Duranti, Giorgio Tarzia

Chemistry & Biodiversity, 2005

View PDFchevron_right

In Silico Studies of Novel 2-(2-(4-Aryloxybenzylidene)-Hydrazinyl)-Benzothiazole derivatives as Anti-Tubercular Agents: 3D QSAR Study

International Journal of Medical Research and Pharmaceutical Sciences

View PDFchevron_right

Computer-aided molecular design of (E)-N-Aryl-2-ethene-sulfonamide analogues as microtubule targeted agents in prostate cancer

Jahan B. Ghasemi

Arabian Journal of Chemistry, 2015

View PDFchevron_right

Pharmacophore, atom-based 3D-QSAR modeling and binding mode analysis of QcrB inhibitors as potential tuberculosis agents

Debnath Pal

Research Square (Research Square), 2023

View PDFchevron_right

Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors

Carlos Varas

Computational and Structural Biotechnology Journal, 2021

View PDFchevron_right

Extracting the significant descriptors by 2D QSAR and docking efficiency of NRTI drugs:A Molecular Modeling Approach

Amit K U M A R Banerjee

View PDFchevron_right

Identification of Potential C-kit Protein Kinase Inhibitors Associated with Human Liver Cancer: Atom-based 3D-QSAR Modeling, Pharmacophores-based Virtual Screening and Molecular Docking Studies

Wacothon-Karime Coulibaly

American Journal of Pharmacological Sciences, 2021

View PDFchevron_right

Prediction of Binding Affinities for Hydroxamic Acid Derivatives as Urease Inhibitors by Molecular Docking and 3D-QSAR Studies

Abdul Wadood

Letters in Drug Design & Discovery, 2009

View PDFchevron_right